Research and Markets (http://www.researchandmarkets.com/research/fvgj86/global) has announced the addition of the "Global Metabolomics Market 2012-2016" report to their offering.
TechNavio's analysts forecast the Global Metabolomics market to grow at a CAGR of 14.95 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant advancements in R&D activities. The Global Metabolomics market has also been witnessing the emergence of coordination of standards in metabolomics. However, the low adoption of metabolomics technology, especially among large pharmaceutical companies could pose a challenge to the small vendors and therefore the growth of this market.
The key vendors dominating this market space are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., Human Metabolome Technologies Inc., and Metabolon Inc.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Recently, the Global Metabolomics market has been witnessing a significant increase in the number of product launches. For instance, Applied Biosystems inc. launched new TaqMan genotyping assays in 2009. Bio-Rad Laboratories introduced Bio-Plex Pro cell signaling assays in July 2012. Moreover, Bio-Rad introduced Bio-Plex assays for immunology and cancer biomarker research in March 2012. Bruker announced new quantitative proteomics capabilities with Skyline software in September 2012. GenoLogics Life Sciences Software Inc. announced the availability of the GenoLogics Rapid Scripting Application Programming Interface (API) for scientific programmers and bioinformaticians in February 2011.''
According to the report, most of the reputable vendors in the Global Metabolomics market are investing significantly in RandD to develop advanced technologies. Moreover, researchers from the University of Washington created disk-shaped patches to inspect the option of generating new tissues with the help of oxygen and nutrient supplies necessary for living cells. Furthermore, scientists at the University of Bristol in the UK developed new scaffolds that can be used to grow such tissues as skin, nerves, and cartilage. These significant developments and initiatives in R&D are expected to drive the growth of the Global Metabolomics market during the period 2012-2016.
For more information visit http://www.researchandmarkets.com/research/fvgj86/globalBusiness Wire
Last updated on: 16/01/2013